The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies
- 1 December 2003
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 14 (suppl_5), v9-v13
- https://doi.org/10.1093/annonc/mdg750
Abstract
F. Berrino; The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies, Annals of Oncology, Volume 14, IssueThis publication has 16 references indexed in Scilit:
- Stage at diagnosis is a key explanation of differences in breast cancer survival across EuropeInternational Journal of Cancer, 2003
- Differences in stage and therapy for breast cancer across EuropeInternational Journal of Cancer, 2001
- The EUROCARE study of survival of cancer patients in EuropeEuropean Journal Of Cancer, 2001
- Childhood cancer survival in Europe, 1978–1992European Journal Of Cancer, 2001
- Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution studyGut, 2000
- Effect of improved data collection on breast cancer incidence and survival: reconciliation of a registry with a clinical databaseBMJ, 2000
- UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 yearsThe Lancet, 2000
- Completeness of cancer registration: a new method for routine useBritish Journal of Cancer, 2000
- EUROCARE-2: relevance for assessment of quality of cancer services?The Lancet, 2000
- A computer program package for relative survival analysisComputer Programs in Biomedicine, 1985